Fujii N - Search Results

1

Therapeutic potential of the chemokine receptor CXCR4 antagonists as multifunctional agents.

Tsutsumi H, Tanaka T, Ohashi N, Masuno H, Tamamura H, Hiramatsu K, Araki T, Ueda S, Oishi S, Fujii N. Tsutsumi H, et al. Among authors: fujii n. Biopolymers. 2007;88(2):279-89. doi: 10.1002/bip.20653. Biopolymers. 2007. PMID: 17167792 Review.

2

The therapeutic potential of CXCR4 antagonists in the treatment of HIV.

Fujii N, Nakashima H, Tamamura H. Fujii N, et al. Expert Opin Investig Drugs. 2003 Feb;12(2):185-95. doi: 10.1517/13543784.12.2.185. Expert Opin Investig Drugs. 2003. PMID: 12556213 Review.

3

Development of anti-HIV agents targeting dynamic supramolecular mechanism: entry and fusion inhibitors based on CXCR4/CCR5 antagonists and gp41-C34-remodeling peptides.

Tamamura H, Otaka A, Fujii N. Tamamura H, et al. Among authors: fujii n. Curr HIV Res. 2005 Oct;3(4):289-301. doi: 10.2174/157016205774370429. Curr HIV Res. 2005. PMID: 16250877 Review.

4

The therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritis.

Tamamura H, Fujii N. Tamamura H, et al. Among authors: fujii n. Expert Opin Ther Targets. 2005 Dec;9(6):1267-82. doi: 10.1517/14728222.9.6.1267. Expert Opin Ther Targets. 2005. PMID: 16300475 Review.

5

Structure-activity relationship studies on CXCR4 antagonists having cyclic pentapeptide scaffolds.

Tamamura H, Esaka A, Ogawa T, Araki T, Ueda S, Wang Z, Trent JO, Tsutsumi H, Masuno H, Nakashima H, Yamamoto N, Peiper SC, Otaka A, Fujii N. Tamamura H, et al. Among authors: fujii n. Org Biomol Chem. 2005 Dec 21;3(24):4392-4. doi: 10.1039/b513145f. Epub 2005 Nov 15. Org Biomol Chem. 2005. PMID: 16327900

6

Identification of a new class of low molecular weight antagonists against the chemokine receptor CXCR4 having the dipicolylamine-zinc(II) complex structure.

Tamamura H, Ojida A, Ogawa T, Tsutsumi H, Masuno H, Nakashima H, Yamamoto N, Hamachi I, Fujii N. Tamamura H, et al. Among authors: fujii n. J Med Chem. 2006 Jun 1;49(11):3412-5. doi: 10.1021/jm060025u. J Med Chem. 2006. PMID: 16722661

7

Development of a linear type of low molecular weight CXCR4 antagonists based on T140 analogs.

Tamamura H, Tsutsumi H, Masuno H, Mizokami S, Hiramatsu K, Wang Z, Trent JO, Nakashima H, Yamamoto N, Peiper SC, Fujii N. Tamamura H, et al. Among authors: fujii n. Org Biomol Chem. 2006 Jun 21;4(12):2354-7. doi: 10.1039/b603818b. Epub 2006 May 12. Org Biomol Chem. 2006. PMID: 16763678

8

The chemokine receptor CXCR4 as a therapeutic target for several diseases.

Tamamura H, Tsutsumi H, Fujii N. Tamamura H, et al. Among authors: fujii n. Mini Rev Med Chem. 2006 Sep;6(9):989-95. doi: 10.2174/138955706778195135. Mini Rev Med Chem. 2006. PMID: 17017998 Review.

9

Development of low molecular weight CXCR4 antagonists by exploratory structural tuning of cyclic tetra- and pentapeptide-scaffolds towards the treatment of HIV infection, cancer metastasis and rheumatoid arthritis.

Tamamura H, Tsutsumi H, Masuno H, Fujii N. Tamamura H, et al. Among authors: fujii n. Curr Med Chem. 2007;14(1):93-102. doi: 10.2174/092986707779313499. Curr Med Chem. 2007. PMID: 17266570 Review.

10

Structure-activity relationship study of CXCR4 antagonists bearing the cyclic pentapeptide scaffold: identification of the new pharmacophore.

Tanaka T, Tsutsumi H, Nomura W, Tanabe Y, Ohashi N, Esaka A, Ochiai C, Sato J, Itotani K, Murakami T, Ohba K, Yamamoto N, Fujii N, Tamamura H. Tanaka T, et al. Among authors: fujii n. Org Biomol Chem. 2008 Dec 7;6(23):4374-7. doi: 10.1039/b812029c. Epub 2008 Oct 17. Org Biomol Chem. 2008. PMID: 19005596

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,111 results

Search Page

Filters